When it comes to cancer, time is everything. However, for many patients, potentially life-changing treatments remain within the confines of ongoing clinical trials.Immunocine was founded to bridge this gap. The sole purpose isto bring a revolutionary immunotherapy to cancer patients unable to participate in the clinical trials.